Editor's Note: TheStreet ratings do not represent the views of TheStreet's staff or its contributors. Ratings are established by computer based on metrics for performance (which includes growth, stock performance, efficiency and valuation) and risk (volatility and solvency). Companies with poor cash flow or high debt levels tend to earn lower ratings in our model. Monsanto Company ( MON) pushed the Chemicals industry higher today making it today's featured chemicals winner. The industry as a whole closed the day up 0.2%. By the end of trading, Monsanto Company rose $1.51 (1.5%) to $103.51 on average volume. Throughout the day, 3.1 million shares of Monsanto Company exchanged hands as compared to its average daily volume of 2.5 million shares. The stock ranged in a price between $101.50-$103.52 after having opened the day at $101.51 as compared to the previous trading day's close of $102. Other companies within the Chemicals industry that increased today were: Methes Energies International ( MEIL), up 34.7%, BioFuel Energy Corporation ( BIOF), up 22.4%, Flotek Industries ( FTK), up 3%, and Senomyx ( SNMX), up 2.3%.
EXCLUSIVE OFFER: Jim Cramer's Protégé, Dave Peltier, only buys Stocks Under $10 that he thinks could potentially double. See what he's trading today with a 14-day FREE pass.
Monsanto Company, together with its subsidiaries, provides agricultural products for farmers worldwide. It operates in two segments, Seeds and Genomics, and Agricultural Productivity. Monsanto Company has a market cap of $55.09 billion and is part of the basic materials sector. The company has a P/E ratio of 24.7, above the S&P 500 P/E ratio of 17.7. Shares are up 8.6% year to date as of the close of trading on Thursday. Currently there are 12 analysts that rate Monsanto Company a buy, one analyst rates it a sell, and five rate it a hold. TheStreet Ratings rates Monsanto Company as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures, impressive record of earnings per share growth, compelling growth in net income and expanding profit margins. Although no company is perfect, currently we do not see any significant weaknesses which are likely to detract from the generally positive outlook.